At A Glance
- Adipotide is an experimental compound designed around the blood vessels serving white fat tissue. That gives it a very different research strategy from appetite-related peptides.
- The 2011 study reported reduced body weight and improved insulin sensitivity.
- Adipotide was designed to direct a pro-apoptotic sequence toward selected vessels.
What Is ADIPOTIDE?
Adipotide is an experimental compound designed around the blood vessels serving white fat tissue. That gives it a very different research strategy from appetite-related peptides.
Its design pairs a targeting region with a region that promotes cell death. The proposed target involves prohibitin-associated vessels in white adipose tissue. Researchers are asking whether that tissue’s blood supply can be selectively affected.
Why Is It Discussed Alongside Metabolic Compounds?
An animal study reported body-weight and insulin-sensitivity changes in obese rhesus monkeys. That result brought attention to the vascular-targeting idea, but the mechanism is quite separate from changing appetite signals.
How Does It Differ From GLP-1 Compounds?
GLP-1-related designs work through metabolic hormone receptors. Adipotide aims a cell-disrupting action at selected blood vessels. The monkey study also reported reversible kidney effects, an important finding to read alongside the weight changes. This remains experimental targeting research.
A Closer Look At ADIPOTIDE
Here are the key observations and the context that helps explain them. The original sources are linked below if you would like to explore further.
| Study or context | What was explored | What it tells us | Useful context |
|---|---|---|---|
| Animal study | Obese rhesus monkeys | The 2011 study reported reduced body weight and improved insulin sensitivity. | Reversible renal effects were also reported. |
| Mechanism | Targeting fat-tissue vasculature | Adipotide was designed to direct a pro-apoptotic sequence toward selected vessels. | This is a distinct strategy from incretin or amylin signalling, with its own safety questions. |
Common Questions About ADIPOTIDE
What is ADIPOTIDE?+
Adipotide is an experimental compound designed around the blood vessels serving white fat tissue. That gives it a very different research strategy from appetite-related peptides.
Why is it discussed alongside metabolic compounds?+
An animal study reported body-weight and insulin-sensitivity changes in obese rhesus monkeys. That result brought attention to the vascular-targeting idea, but the mechanism is quite separate from changing appetite signals.
How does it differ from GLP-1 compounds?+
GLP-1-related designs work through metabolic hormone receptors. Adipotide aims a cell-disrupting action at selected blood vessels. The monkey study also reported reversible kidney effects, an important finding to read alongside the weight changes. This remains experimental targeting research.
Sources
Want to go a little deeper? These links take you to the studies and official records behind the guide. Study registries describe the plan; published papers report the findings.
- the primary primate studyPeer-reviewed publication · Linked record
A 2011 study reported reductions in body weight and improved insulin sensitivity in obese rhesus monkeys after a prohibitin-targeting peptidomimetic. It was preclinical work and included reversible renal effects.
- Think twice before injecting peptides bought online: unauthorized products can seriously harm youHealth Canada · 2026
For ADIPOTIDE context, this official Canadian advisory explains why a research-use label does not establish authorization, safety, efficacy, or product quality for human use.
Vote For ADIPOTIDE
This compound is not currently stocked. Add it to your five-choice catalogue ballot.